Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
暂无分享,去创建一个
Florian Bayer | Chantal Guihenneuc | B. Stengel | V. Lemaître | C. Guihenneuc | C. Couchoud | F. Bayer | P. Brunet | Bénédicte Stengel | Cécile Couchoud | Vincent Lemaitre | Philippe Brunet
[1] W. Hörl,et al. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] P. Whelton,et al. End-Stage Renal Disease Attributable to Diabetes Mellitus , 1994, Annals of Internal Medicine.
[3] C. McCulloch,et al. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[4] R. Arnold,et al. Dialysis in frail elders--a role for palliative care. , 2009, The New England journal of medicine.
[5] Josef Coresh,et al. Conceptual model of CKD: applications and implications. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] Xiao-Li Meng,et al. POSTERIOR PREDICTIVE ASSESSMENT OF MODEL FITNESS VIA REALIZED DISCREPANCIES , 1996 .
[7] C Pascutto,et al. Statistical issues in the analysis of disease mapping data. , 2000, Statistics in medicine.
[8] J. Stewart,et al. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] P. Roderick,et al. What Determines Geographical Variation in Rates of Acceptance onto Renal Replacement Therapy in England? , 1999, Journal of health services research & policy.
[10] B. Stengel,et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). , 2005, Kidney international.
[11] T. Usami,et al. Regional variations in the incidence of end-stage renal failure in Japan. , 2000, JAMA.
[12] R. Wolfe,et al. Socioeconomic status and end-stage renal disease in the United States. , 1994, Kidney international.
[13] E. Lesaffre,et al. Disease mapping and risk assessment for public health. , 1999 .
[14] Peter Green,et al. Highly Structured Stochastic Systems , 2003 .
[15] J. Besag,et al. Bayesian image restoration, with two applications in spatial statistics , 1991 .
[16] A. Morris,et al. Socio‐economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[17] Lance A Waller,et al. Small-Area Racial Disparity in Stroke Mortality: An Application of Bayesian Spatial Hierarchical Modeling , 2009, Epidemiology.
[18] Sylvia Richardson,et al. A comparison of Bayesian spatial models for disease mapping , 2005, Statistical methods in medical research.
[19] P. Roderick,et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] P. Ridker,et al. Impact of Traditional and Novel Risk Factors on the Relationship Between Socioeconomic Status and Incident Cardiovascular Events , 2006, Circulation.
[21] E. Ejerblad,et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] N. G. Best,et al. Outdoor NOx and stroke mortality: adjusting for small area level smoking prevalence using a Bayesian approach , 2006, Statistical methods in medical research.
[23] S. Lipsitz,et al. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. , 2007, Health & place.
[24] S. Rasmussen,et al. Regional and social inequalities in chronic renal replacement therapy in Denmark. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] J. Wakefield,et al. Bayesian approaches to disease mapping , 2001 .
[26] B. Stengel,et al. The timing of dialysis initiation affects the incidence of renal replacement therapy. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] A. Zwinderman,et al. Global variation in renal replacement therapy for end-stage renal disease. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] E. Goyder,et al. CKD and poverty: a growing global challenge. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[30] W. McClellan,et al. Risk factors for progressive chronic kidney disease. , 2003, Journal of the American Society of Nephrology : JASN.
[31] Paul Landais,et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] M. McCredie,et al. Factors influencing reported rates of treated end-stage renal disease. , 2005, Advances in chronic kidney disease.
[33] N. Powe,et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. , 2003, Journal of the American Society of Nephrology : JASN.
[34] S. Wild,et al. Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[35] J. Wakefield,et al. Spatial epidemiology: methods and applications. , 2000 .
[36] D. Kleinbaum,et al. Neighborhood poverty and racial differences in ESRD incidence. , 2008, Journal of the American Society of Nephrology : JASN.
[37] M. Ward. Socioeconomic status and the incidence of ESRD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] I. Kawachi,et al. Income inequality, mortality, and self rated health: meta-analysis of multilevel studies , 2009, BMJ : British Medical Journal.
[39] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[40] T. Raghunathan,et al. Education, income, occupation, and the 34-year incidence (1965-99) of Type 2 diabetes in the Alameda County Study. , 2005, International journal of epidemiology.
[41] J. Rutledge,et al. THIRTEENTH ANNUAL REPORT , 1601 .
[42] A. Cass,et al. Regional variation in the incidence of end‐stage renal disease in Indigenous Australians , 2001, The Medical journal of Australia.
[43] Michael F Goodchild,et al. Toward critical spatial thinking in the social sciences and humanities , 2010, GeoJournal.